Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 4676 - 4700 of 5621 in total

BI-187004

Investigational

ANC-501

ANC-501 is under investigation in clinical trial NCT05439603 (ANC-501 in the Treatment of Adults With Major Depressive Disorder).
Investigational

MK-8189

MK-8189 is under investigation in clinical trial NCT04624243 (Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)).
Investigational

Tuvirumab

Investigational

Edobacomab

Investigational

Zelpultide alfa

Zelpultide alfa is a recombinant human surfactant protein D.
Investigational

[1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester

Experimental

Tricarbonyl(1,10-phenanthroline)rhenium(1+)

Experimental

2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide

Experimental

Pirlindole

This drug is classified as a reversible inhibitor of monoamine oxidase A enzyme (also known as a RIMA drug). It was developed and is currently used as an antidepressant in Russia. Its chemical structure is similar to metralindole, and it also shares pharmacological properties with this drug. Pirlindole is a...
Experimental

Expanded human allogeneic neural retinal progenitor cells extracted from neural retina

Investigational

Quinoline

Investigational

Nedometinib

Investigational

TTX-siPDL1

TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.
Investigational

Vonafexor

Investigational

Atrial natriuretic peptide

Experimental

SY-5609

Investigational

Pirmitegravir

Pirmitegravir is under investigation in clinical trial NCT05869643 (A Clinical Trial of STP0404 in Treatment-naïve Adults With HIV-1 Infection).
Investigational

Oxfendazole

Oxfendazole is a sulfoxide metabolite of fenbendazole. This benzimidazole antihelminthic protects livestock from roundworm. strongyles, and pinworn.
Investigational
Vet approved

Amuvatinib

Amuvatinib has been used in trials studying the treatment of Solid Tumors and Small Cell Lung Carcinoma. Amuvatinib is an oral, selective multi-targeted tyrosine kinase inhibitor that suppresses c-MET, c-RET and the mutant forms of c-KIT, PDGFR and FLT3. Amuvatinib also suppresses Rad51 protein, a critical component of double-stranded DNA...
Investigational
Matched Description: … Amuvatinib is an oral, selective multi-targeted tyrosine kinase inhibitor that suppresses c-MET, c-RET ... and the mutant forms of c-KIT, PDGFR and FLT3. …

USL-311

USL-311 is under investigation in clinical trial NCT02765165 (Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)).
Investigational

1-Carboxyethylaminomethyl-4-Aminomethylbenzene

Experimental

2-Amino-3-(Cystein-S-Yl)-Isoxazolidin-5-Yl-Acetic Acid

Experimental

N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE

Experimental

6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE

Experimental
Displaying drugs 4676 - 4700 of 5621 in total